BOSTON — The first formal phase 1 study of mesenchymal stem cells for multiple sclerosis (MS) to be conducted in North America has shown no safety issues. "The goal was to show safety, feasibility and ...
The Belgrade hospital brings inpatient care, rehabilitation, and laboratory services under one roof, supported by 31+ ...
West Palm Beach, Florida — In an interim analysis of an extension study, intrathecal injection of autologous bone marrow–derived mesenchymal stem cells (MSCs) has been associated with favorable ...
Leading U.S. stem cell banking and cellular therapeutic manufacturer Hope Biosciences announces the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) ...
Hemodialysis is a treatment in which a machine filters waste from the blood. To prepare for it, patients typically undergo ...
Mesenchymal stem cells (MSCs) are unique adult stem cells with immunosuppressive properties that also may play a key role in preventing autoimmunity. In a new study, researchers identified metabolic ...
The agency found that Gallant’s data provides reasonable expectation of effectiveness.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback